Andrew Wilson

Board Director at Purespring Therapeutics

Andrew is a Senior Research Commercialisation Manager at the University of Bristol. He works with academic colleagues from the University’s Faculty of Health Sciences to facilitate the translation and commercialisation of a range of technologies and healthcare interventions.

This includes licensing and new company creation. Andrew has 20 years’ experience in Technology Transfer roles and is an experienced non-executive director who currently serves on the board of a number of therapeutic, medical device and public health focused spin-out companies.

Timeline

  • Board Director

    Current role